Ambler class |
Protein name |
PDB code |
Resolution (Å) |
Release date |
UniProt code |
PubMed ID |
DOI |
PDB |
Mutations |
Ligands |
Space group |
Unit cell parameters |
Z value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
▲ ▼ | ▲ ▼ | ▲ ▼ | ▲ ▼ | ▲ ▼ | ▲ ▼ | ||||||||
C | ACT-89 | 1BLS | 2.30 | 1995-05-08 | P05364 | 8204611 | 10.1021/BI00188A004 | pdb | *IPP | P 1 21 1 | 46.500 83.470 95.460 ♦ 90.00 90.01 90.00 | 4 | |
C | ACT-89 | 1XX2 | 1.88 | 2004-11-23 | P05364 | — | — | pdb | P 1 21 1 | 46.500 83.470 95.460 ♦ 90.00 90.01 90.00 | 4 | ||
C | ACT-89 | 2Q9M | 2.05 | 2007-08-21 | P05364 | 17665896 | 10.1021/JM0703237 | pdb | *LK7 | P 21 21 2 | 76.652 69.776 62.818 ♦ 90.00 90.00 90.00 | 4 | |
C | ACT-89 | 2Q9N | 2.20 | 2007-08-21 | P05364 | 17665896 | 10.1021/JM0703237 | pdb | *LK5 | P 21 21 2 | 77.377 68.984 62.020 ♦ 90.00 90.00 90.00 | 4 | |
C | ACT-89 | 3S4X | 1.95 | 2012-08-01 | P05364 | 22948919 | 10.1107/S0907444912024080 | pdb | N152G A88P I16V A299V | SO4 | P 21 21 2 | 78.956 85.481 51.681 ♦ 90.00 90.00 90.00 | 4 |
C | ACT-89 | 4XUX | 1.75 | 2015-04-01 | P05364 | 25782055 | 10.1021/ACS.JMEDCHEM.5B00127 | pdb | *4D6 EDO PG0 | P 2 21 21 | 62.560 69.600 76.330 ♦ 90.00 90.00 90.00 | 4 | |
C | ACT-89 | 5HAI | 2.74 | 2016-09-07 | P05364 | 27073009 | 10.1021/ACS.BIOCHEM.6B00056 | pdb | S64G | PO4 | P 2 21 21 | 61.860 69.430 78.140 ♦ 90.00 90.00 90.00 | 4 |
C | ACT-89 | 5XHR | 1.80 | 2017-09-27 | P05364 | 28971874 | 10.1128/AAC.01288-17 | pdb | $PXH | P 2 21 21 | 61.160 69.330 76.850 ♦ 90.00 90.00 90.00 | 4 | |
C | ACT-89 | 7TI1 | 2.00 | 2023-01-25 | P05364 | pdb | *ZXQ CL EDO | P 21 21 2 | 68.960 77.980 62.260 ♦ 90.00 90.00 90.00 | 4 |
Statistics (number of structures): Overall (1663); class A (626); subclass B1 (403); subclass B2 (16); subclass B3 (104); class C (246); class D (268).
Last updated: November 20, 2024.
If you use BLDB please cite: Naas, T.; Oueslati, S.; Bonnin, R. A.; Dabos, M. L.; Zavala, A.; Dortet, L.; Retailleau, P.; Iorga, B. I., Beta-Lactamase DataBase (BLDB) – Structure and Function. J. Enzyme Inhib. Med. Chem. 2017, 32, 917-919.
The development of the BLDB database was funded in part by the JPIAMR transnational project DesInMBL, the Région Ile-de-France (DIM Malinf) and the Laboratory of Excellence in Research on Medication and Innovative Therapeutics (LERMIT).
Contact: contact@bldb.eu